Determinants of medical care for young women with Turner syndrome.
BACKGROUND
Turner syndrome is associated with reduced life expectancy. Lifelong follow-up is strongly recommended, but follow-up during the transition between pediatric and adult care has been little evaluated.


OBJECTIVE
Our objective was to evaluate the medical follow-up of a population-based cohort of young adult patients.


METHODS
A questionnaire study was conducted with a national cohort of 568 women, aged 22.6 +/- 2.6 yr (range, 18.3-31.2), a mean of 6 yr after stopping GH treatment (StaTur cohort).


METHODS
We assessed the proportion of patients with adequate follow-up at seven medical assessments over 4 yr and its determinants.


RESULTS
Most participants were followed by gynecologists or general practitioners. Medical assessments were performed in 16% (audiometry) to 68% (lipid level determinations) of participants, with little consistency in individual patients. Only 20 of 568 patients (3.5%) underwent all assessments in the 4-yr period. Multivariate analysis identified the type of physician as the only factor consistently associated with follow-up, which was more adequate with endocrinologists than with other physicians. Other variables associated with at least one adequate follow-up assessment were paternal socioeconomic class, education level, number of Turner syndrome disease components, size of the medical center following the patient in childhood, and physical health dimensions of Short Form 36 questionnaire.


CONCLUSIONS
By contrast with the intensive medical follow-up in childhood, follow-up was grossly inadequate during the transition phase. During this phase, patients should be sent to physicians specializing in Turner syndrome and particular attention should be paid to patients with lower levels of education and from families of low socioeconomic status.
Devernay
Marie
M
Pediatric Endocrinology and Institut National de la Santé et de la Recherche Médicale, Unité 690, Hôpital Robert Debré, 48 boulevard Sérurier, 75019 Paris, France.
Ecosse
Emmanuel
E
Coste
Joël
J
Carel
Jean-Claude
JC
D000293:Adolescent; D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D015999:Multivariate Analysis; D011446:Prospective Studies; D014424:Turner Syndrome / Q000628:therapy*
D019382:Human Growth Hormone